234 related articles for article (PubMed ID: 15163296)
1. High-resolution serum proteomic features for ovarian cancer detection.
Conrads TP; Fusaro VA; Ross S; Johann D; Rajapakse V; Hitt BA; Steinberg SM; Kohn EC; Fishman DA; Whitely G; Barrett JC; Liotta LA; Petricoin EF; Veenstra TD
Endocr Relat Cancer; 2004 Jun; 11(2):163-78. PubMed ID: 15163296
[TBL] [Abstract][Full Text] [Related]
2. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
Liu XP; Shen J; Li ZF; Yan L; Gu J
Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
[TBL] [Abstract][Full Text] [Related]
3. Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer.
Pietrowska M; Marczak L; Polanska J; Behrendt K; Nowicka E; Walaszczyk A; Chmura A; Deja R; Stobiecki M; Polanski A; Tarnawski R; Widlak P
J Transl Med; 2009 Jul; 7():60. PubMed ID: 19594898
[TBL] [Abstract][Full Text] [Related]
4. Proteomic studies of early-stage and advanced ovarian cancer patients.
Wang J; Zhang X; Ge X; Guo H; Xiong G; Zhu Y
Gynecol Oncol; 2008 Oct; 111(1):111-9. PubMed ID: 18703221
[TBL] [Abstract][Full Text] [Related]
5. Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/ml.
Ornstein DK; Rayford W; Fusaro VA; Conrads TP; Ross SJ; Hitt BA; Wiggins WW; Veenstra TD; Liotta LA; Petricoin EF
J Urol; 2004 Oct; 172(4 Pt 1):1302-5. PubMed ID: 15371828
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic potential of serum proteomic patterns in prostate cancer.
Bañez LL; Prasanna P; Sun L; Ali A; Zou Z; Adam BL; McLeod DG; Moul JW; Srivastava S
J Urol; 2003 Aug; 170(2 Pt 1):442-6. PubMed ID: 12853795
[TBL] [Abstract][Full Text] [Related]
7. Serum diagnosis of diffuse large B-cell lymphomas and further identification of response to therapy using SELDI-TOF-MS and tree analysis patterning.
Zhang X; Wang B; Zhang XS; Li ZM; Guan ZZ; Jiang WQ
BMC Cancer; 2007 Dec; 7():235. PubMed ID: 18163913
[TBL] [Abstract][Full Text] [Related]
8. Using proteomic approaches to identify new biomarkers for detection and monitoring of ovarian cancer.
Kong F; Nicole White C; Xiao X; Feng Y; Xu C; He D; Zhang Z; Yu Y
Gynecol Oncol; 2006 Feb; 100(2):247-53. PubMed ID: 16229881
[TBL] [Abstract][Full Text] [Related]
9. Plasma proteomic pattern as biomarkers for ovarian cancer.
Lin YW; Lin CY; Lai HC; Chiou JY; Chang CC; Yu MH; Chu TY
Int J Gynecol Cancer; 2006; 16 Suppl 1():139-46. PubMed ID: 16515582
[TBL] [Abstract][Full Text] [Related]
10. High-resolution serum proteomic profiling of Alzheimer disease samples reveals disease-specific, carrier-protein-bound mass signatures.
Lopez MF; Mikulskis A; Kuzdzal S; Bennett DA; Kelly J; Golenko E; DiCesare J; Denoyer E; Patton WF; Ediger R; Sapp L; Ziegert T; Lynch C; Kramer S; Whiteley GR; Wall MR; Mannion DP; Della Cioppa G; Rakitan JS; Wolfe GM
Clin Chem; 2005 Oct; 51(10):1946-54. PubMed ID: 16081505
[TBL] [Abstract][Full Text] [Related]
11. Proteomic patterns for classification of ovarian cancer and CTCL serum samples utilizing peak pairs indicative of post-translational modifications.
Liu C; Shea N; Rucker S; Harvey L; Russo P; Saul R; Lopez MF; Mikulskis A; Kuzdzal S; Golenko E; Fishman D; Vonderheid E; Booher S; Cowen EW; Hwang ST; Whiteley GR
Proteomics; 2007 Nov; 7(22):4045-52. PubMed ID: 17952875
[TBL] [Abstract][Full Text] [Related]
12. [Study for drug-resistance of epithelial ovarian cancer by serum protein profiling].
Zhang WY; Zhu LR; Zheng YH; Zhou L; Zhang JZ; Wu JH; Liao QP
Zhonghua Yi Xue Za Zhi; 2009 May; 89(19):1326-9. PubMed ID: 19615186
[TBL] [Abstract][Full Text] [Related]
13. Novel approaches to visualization and data mining reveals diagnostic information in the low amplitude region of serum mass spectra from ovarian cancer patients.
Johann DJ; McGuigan MD; Tomov S; Fusaro VA; Ross S; Conrads TP; Veenstra TD; Fishman DA; Whiteley GR; Petricoin EF; Liotta LA
Dis Markers; 2003-2004; 19(4-5):197-207. PubMed ID: 15258334
[TBL] [Abstract][Full Text] [Related]
14. [Identification of serum biomarkers for ovarian cancer using protein chips and time of flight mass spectrometry technology].
Wang Q; Li L; Li DR; Zhang W; Wei X; Zhang JQ; Tang Y
Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):544-8. PubMed ID: 17083841
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer.
Yildiz PB; Shyr Y; Rahman JS; Wardwell NR; Zimmerman LJ; Shakhtour B; Gray WH; Chen S; Li M; Roder H; Liebler DC; Bigbee WL; Siegfried JM; Weissfeld JL; Gonzalez AL; Ninan M; Johnson DH; Carbone DP; Caprioli RM; Massion PP
J Thorac Oncol; 2007 Oct; 2(10):893-901. PubMed ID: 17909350
[TBL] [Abstract][Full Text] [Related]
16. Investigation of early and advanced stages in ovarian cancer using human plasma by differential scanning calorimetry and mass spectrometry.
Kim NA; Jin JH; Kim KH; Lim DG; Cheong H; Kim YH; Ju W; Kim SC; Jeong SH
Arch Pharm Res; 2016 May; 39(5):668-76. PubMed ID: 27002828
[TBL] [Abstract][Full Text] [Related]
17. Analysis of variabilities of serum proteomic spectra in patients with gastric cancer before and after operation.
Ren H; Du N; Liu G; Hu HT; Tian W; Deng ZP; Shi JS
World J Gastroenterol; 2006 May; 12(17):2789-92. PubMed ID: 16718772
[TBL] [Abstract][Full Text] [Related]
18. Highly sensitive detection of melanoma based on serum proteomic profiling.
Caron J; Mangé A; Guillot B; Solassol J
J Cancer Res Clin Oncol; 2009 Sep; 135(9):1257-64. PubMed ID: 19288131
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of proteomics-identified CCL18 and CXCL1 as circulating tumor markers for differential diagnosis between ovarian carcinomas and benign pelvic masses.
Wang Q; Li D; Zhang W; Tang B; Li QQ; Li L
Int J Biol Markers; 2011; 26(4):262-73. PubMed ID: 21928244
[TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis for early detection of ovarian cancer: a realistic approach?
Stevens EV; Liotta LA; Kohn EC
Int J Gynecol Cancer; 2003; 13 Suppl 2():133-9. PubMed ID: 14656269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
